Assessment of Calamus tenuis fruits extract on blood glucose level elevation and its antibacterial potency
Keywords:Antibacterial, Blood glucose level, Extraction, Calamus tenuis, positive control
Investigation of anti-hyperglycemic and antibacterial activity of the fruit extract of Calamus tenuis was carried out. Soxhlet extraction was done using petroleum ether, ethyl acetate and methanol. Anti-hyperglycemic activity was done by Oral Glucose Tolerance Test.The results indicated that methanol extract (500 mg/Kg) showed nearly same potency of blood glucose lowering capacity (4.82 ± 0.730 mmol/L) compared to the glibenclamide (standard drug). Antibacterial activity was investigated using disc diffusion method. Antibacterial tests revealed that S. aureus was resistant to all the solvent extracts. Ethyl acetate and methanol extracts showed moderate antibacterial capacity against both Micrococcus and V. cholerea whereas petroleum ether showed nothing. Zone of inhibition of Ethyl acetate and methanol extracts (200 mg/mL dose) for E. coli were very close to positive control (17.00 ± 0.816 and 18.75 ± 1.258 mm respectively; positive control value was 19.00 ± 1.414 and 21.00 ± 1.414 respectively ). In case of methanol zone of inhibitions were greater than other solvent extracts against all tested bacterial species. From the present research it can be recapitulated that due to the biological activity of C. tenuis fruit it may satisfy as a new candidate for the emergence of medicines.
How to Cite
Copyright (c) 2020 Hema Sarkar, Tasfia Sharin, Muhammad Shamim Al Mamun
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.